MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-02-0009536
Safron Pharmaceuticals Private Limited
Safron Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.28 Cr
▼ 41% YoY
Net loss · FY 2024
₹3.35 Lakh
Net margin -2.6%
EBITDA · FY 2024
₹3.92 Lakh
EBITDA margin 3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
5
As per MCA filings
About Safron Pharmaceuticals Private Limited
Data last updated:
Safron Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 08 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2010PTC210796. Its GSTIN is 08AAQCS5455A1Z7 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manish Mittal and Sanju Vijay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 12 Kavita Bldg Main Carter Road Next To Icici Bank, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.28 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹3.35 Lakh (net margin -2.6%) and EBITDA of ₹3.92 Lakh (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 20% over five years.
The company is associated with 1 brand: Powernosh Nutrition. As per MCA filings, the company has open charges of ₹40 Lakh on record.
Safron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0009536). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100MH2010PTC210796
Registration Number 210796
Incorporation Date 08 December 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-02-0009536
Recognitions & Rankings of Safron Pharmaceuticals
Contact details
Safron Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 12 Kavita Bldg Main Carter Road Next To Icici Bank, Mumbai, Maharashtra, India – 400066
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Safron Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Safron Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Safron Pharmaceuticals operates one associated brand: Powernosh Nutrition. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform for sexual health, wellness, and grooming products for consumers. | powernoshnutrition.com |
Business activity
The main business activity of Safron Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Safron Pharmaceuticals Private Limited, buy the company report.
Financials of Safron Pharmaceuticals Private Limited
FY 2025 filings availableSafron Pharmaceuticals Private Limited reported revenue of ₹1.28 Cr (down 41% YoY) for FY 2024.
Revenue · FY 2024
₹1.28 Cr ▼ 41%
Net loss · FY 2024
₹3.35 Lakh margin -2.6%
EBITDA · FY 2024
₹3.92 Lakh margin 3.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 11%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 32%
5 years · compounded
▼ 22%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 41% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | -2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Safron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Safron Pharmaceuticals Private Limited
Safron Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Mittal | Director | 18 Jul 2013 | 13 Years 3 Months | Current |
| Sanju Vijay | Director | 08 Dec 2010 | 15 Years 10 Months | Current |
| Mahesh Chand Gupta Also directs: Health First Pharmacy Private Limited | Director | 08 Dec 2010 | 15 Years 10 Months | Current |
| Mukesh Kumar Gupta | Director | 07 Aug 2015 | 11 Years 2 Months | Current |
| Rohit Singhal | Director | 06 Jan 2014 | 12 Years 9 Months | Current |
Auditor
Safron Pharmaceuticals Private Limited is audited by AJAY INDER LAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY INDER LAL & ASSOCIATES | FY 2021 | 009468C |
Shareholding
The shareholding of Safron Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Safron Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2017 | 100133005 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Safron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Safron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Safron Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAQCS5455A1Z7 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Safron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Safron Pharmaceuticals Private Limited has 8 board changes on record since 2010: 5 appointments and 3 cessations. The latest: Mukesh Kumar Gupta ceased to be Additional Director on 30 Sep 2015.
AGM
Safron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Safron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100133005 was registered on 31 Oct 2017.
Ceased
Mukesh Kumar Gupta ceased to be Additional Director.
Appointed
Mukesh Kumar Gupta was appointed as Director.
Ceased
Rohit Singhal ceased to be Additional Director.
Appointed
Rohit Singhal was appointed as Director.
Ceased
Manish Mittal ceased to be Additional Director.
Appointed
Manish Mittal was appointed as Director.
Appointed
Mahesh Chand Gupta was appointed as Director.
Appointed
Sanju Vijay was appointed as Director.
Incorporation
08 Dec 2010
Safron Pharmaceuticals Private Limited was registered on 08 Dec 2010 with Roc Mumbai I & aged 15 years 10 months as per MCA records.
Frequently asked questions
Safron Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 08 December 2010 (16+ years old) and is registered under CIN U85100MH2010PTC210796.
Safron Pharmaceuticals has 5 current directors:
- Manish Mittal - Director
- Sanju Vijay - Director
- Mahesh Chand Gupta - Director
- Mukesh Kumar Gupta - Director
- Rohit Singhal - Director
The latest financial statements of Safron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Safron Pharmaceuticals is 08AAQCS5455A1Z7, registered in Rajasthan.
The CIN (Corporate Identification Number) of Safron Pharmaceuticals is U85100MH2010PTC210796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Safron Pharmaceuticals was incorporated on 08 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Mukesh Kumar Gupta ceased to be Additional Director on 30 Sep 2015. Mukesh Kumar Gupta was appointed as Director on 07 Aug 2015. Rohit Singhal ceased to be Additional Director on 30 Sep 2014. Safron Pharmaceuticals has 8 board changes on record in total.
Yes, Safron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-02-0009536).
The registered office of Safron Pharmaceuticals is at Shop No 12 Kavita Bldg Main Carter Road Next To Icici Bank, Mumbai, Maharashtra, India – 400066.
Safron Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages